1. Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients 
Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen, Lise Saksø Mortensen, Kasper Toustrup, Jens Overgaard, Jan Alsner 
Clinical and Translational Radiation Oncology 
Volume 2, Pages (February 2017)
DOI: /j.ctro
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1
Associations with any failures for patients with a ‘high risk’ or ‘low risk’ profile of proteins in a subgroup of patients (test cohort, A) and replication of the profile in the remaining subgroup of patients (validation cohort, B). ‘High risk’ patients are identified by having expression of at least 5 of 6 proteins in ‘high risk’ expression ranges.
Clinical and Translational Radiation Oncology 2017 2, 46-52DOI: ( /j.ctro )
Copyright © 2017 The Authors Terms and Conditions

3. Fig. 2
Unsupervised clustering of proteins in patients (A) and in controls (B). Associations between clusters and any failures in p16-positive oropharynx patients (C) and other patients (D).
Clinical and Translational Radiation Oncology 2017 2, 46-52DOI: ( /j.ctro )
Copyright © 2017 The Authors Terms and Conditions